Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Huanghai Ruisheng Pharmaceutical is a China-based pharmaceutical company specializing in the development, production, and sale of chemical drug preparations. Headquartered in Jieyang, Guangdong, the company operates GMP-certified manufacturing facilities for various dosage forms, including tablets, capsules, and granules. Its product portfolio is primarily focused on high-prevalence therapeutic areas such as cardiovascular disease, metabolic disorders, and infectious diseases. Key commercial products include Amlodipine Besylate for hypertension and Metformin Hydrochloride for type 2 diabetes. The company is recognized as a National High-tech Enterprise and plays a significant role in the regional pharmaceutical industry in Southern China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Huanghai Ruisheng Pharmaceutical.